Pexelizumab and the APEX AMI trial.
Publication
, Journal Article
Armstrong, PW; Granger, CB
Published in: JAMA
May 2, 2007
Duke Scholars
Published In
JAMA
DOI
EISSN
1538-3598
Publication Date
May 2, 2007
Volume
297
Issue
17
Start / End Page
1881
Location
United States
Related Subject Headings
- Single-Chain Antibodies
- Myocardial Infarction
- Humans
- General & Internal Medicine
- Antibodies, Monoclonal, Humanized
- Antibodies, Monoclonal
- Anti-Inflammatory Agents
- Angioplasty, Balloon, Coronary
- 42 Health sciences
- 32 Biomedical and clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Armstrong, P. W., & Granger, C. B. (2007). Pexelizumab and the APEX AMI trial. JAMA, 297(17), 1881. https://doi.org/10.1001/jama.297.17.1881-b
Armstrong, Paul W., and Christopher B. Granger. “Pexelizumab and the APEX AMI trial.” JAMA 297, no. 17 (May 2, 2007): 1881. https://doi.org/10.1001/jama.297.17.1881-b.
Armstrong PW, Granger CB. Pexelizumab and the APEX AMI trial. JAMA. 2007 May 2;297(17):1881.
Armstrong, Paul W., and Christopher B. Granger. “Pexelizumab and the APEX AMI trial.” JAMA, vol. 297, no. 17, May 2007, p. 1881. Pubmed, doi:10.1001/jama.297.17.1881-b.
Armstrong PW, Granger CB. Pexelizumab and the APEX AMI trial. JAMA. 2007 May 2;297(17):1881.
Published In
JAMA
DOI
EISSN
1538-3598
Publication Date
May 2, 2007
Volume
297
Issue
17
Start / End Page
1881
Location
United States
Related Subject Headings
- Single-Chain Antibodies
- Myocardial Infarction
- Humans
- General & Internal Medicine
- Antibodies, Monoclonal, Humanized
- Antibodies, Monoclonal
- Anti-Inflammatory Agents
- Angioplasty, Balloon, Coronary
- 42 Health sciences
- 32 Biomedical and clinical sciences